RankAlpha logo
Back to Rankings

GRAL

GRAILD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
Current thesis
The constructive case is that Q1 showed continued commercial traction: total revenue rose 28% year over year to $40.8 million, Galleri revenue rose 37% to $39.8 million, and test volume increased 50% to more than 56,000, while cash, cash equivalents, and short-term marketable securities were $823.1 million at March 31, 2026 [#8-K-2026-05-05] [#10-Q-2026-05-07].
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -14.1.
What can break
Broader reimbursement is still limited; GRAIL says it does not currently have broader Medicare or large commercial insurer coverage, which can constrain scale even if clinical interest remains solid [#10-Q-2026-05-07] [#10-K-2026-03-12].
Momentum
62
Value
41
Sentiment
35
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $64.00 · Bull $88.00 · Bear $42.00
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $70.13
Why
Momentum62 · Δ7d -14.1
Value41 · Δ7d +0.1
Sentiment35 · Δ7d +1.3
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
62
26% active weight
Current posture
7d trendSoftening
Δ7d
-14.1
Δ21d
+7.2
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.0
Sentiment
35
34% active weight
Current posture
7d trendImproving
Δ7d
+1.3
Δ21d
-4.3
Why this grade

Composite grade D. Momentum 62.4 / Value 41.1 / Sentiment 34.5

Fundamentals (TTM)
As of 2026-07-21
Market Cap
$3.12B
Beta
-
Shares Out
42.92M
P/E (TTM) · Derived
-6.5
P/S (TTM)
26.32
P/FCF (TTM) · Derived
-9.51
Rev YoY
+28.1%
EPS YoY
-25.9%
Gross Margin
-44.7%
Op Margin
-405.2%
Net Debt
-$849.57M
Current Ratio
11.74
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology